risk-adapted therapy of aml
Published 5 years ago • 56 plays • Length 1:29Download video MP4
Download video MP3
Similar videos
-
1:50
considerations for risk-adapted therapy in lower-risk mds
-
2:26
insights into the future of aml therapy: the increasing use of targeted agents
-
1:21
trends in allosct for good-risk aml: a longitudinal study
-
5:05
determining the most suitable consolidation therapies for aml by defining patient risk group
-
1:55
treatment of intermediate-risk aml with gemtuzumab ozogamicin
-
1:40
the role of menin inhibitors in the treatment of aml
-
52:09
august 26, 2024 id vmr w/dr. dan minter & dr. uttara gadde - first episode of tonic clonic seizure
-
4:30
which gene mutations are categorized as low, intermediate and high risk aml? #aml
-
1:15:04
august 26, 2024 vmr with alec & austin - fever and abdominal pain
-
1:19
telomerase inhibition as a novel targeted therapy for myelofibrosis
-
2:54
how novel agents & individualized treatment approaches are improving outcomes in patients with aml
-
3:47
the impact of cytogenetic-risk stratification on aml outcomes
-
2:34
the evolution of the aml treatment paradigm
-
2:57
the importance of analyzing cytogenetic risk in patients with aml undergoing haploidentical sct
-
1:09
menin inhibitors for the treatment of aml: insights into the covalent-101 trial
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
5:01
treatment options for high-risk aml
-
1:36
targeted therapy for aml
-
1:52
aml: the cytogenetic risk score
-
0:53
go-flag: bridge therapy to allo-sct in r/r aml
-
3:47
the role of immunotherapy in the aml treatment landscape